US8231893B2 - Multicomponent material comprising chitosan - Google Patents
Multicomponent material comprising chitosan Download PDFInfo
- Publication number
- US8231893B2 US8231893B2 US11/471,929 US47192906A US8231893B2 US 8231893 B2 US8231893 B2 US 8231893B2 US 47192906 A US47192906 A US 47192906A US 8231893 B2 US8231893 B2 US 8231893B2
- Authority
- US
- United States
- Prior art keywords
- chitosan
- absorbent structure
- inert carrier
- carrier material
- absorbent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 146
- 239000000463 material Substances 0.000 title claims abstract description 105
- 239000002250 absorbent Substances 0.000 claims abstract description 86
- 230000002745 absorbent Effects 0.000 claims abstract description 86
- 239000012876 carrier material Substances 0.000 claims abstract description 41
- 239000002245 particle Substances 0.000 claims description 23
- 239000000835 fiber Substances 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 15
- -1 polyethylene Polymers 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 230000002378 acidificating effect Effects 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 5
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 229940071139 pyrrolidone carboxylate Drugs 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 3
- 239000006261 foam material Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 2
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 2
- 239000002657 fibrous material Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000002253 acid Substances 0.000 description 16
- 150000007513 acids Chemical class 0.000 description 13
- 239000012530 fluid Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 230000006196 deacetylation Effects 0.000 description 8
- 238000003381 deacetylation reaction Methods 0.000 description 8
- 238000000576 coating method Methods 0.000 description 7
- 239000003431 cross linking reagent Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 229920002101 Chitin Polymers 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000012209 synthetic fiber Substances 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 206010021639 Incontinence Diseases 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical class OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229920001131 Pulp (paper) Polymers 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229910052681 coesite Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052906 cristobalite Inorganic materials 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- DCEMCPAKSGRHCN-UHFFFAOYSA-N oxirane-2,3-dicarboxylic acid Chemical compound OC(=O)C1OC1C(O)=O DCEMCPAKSGRHCN-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 229910052682 stishovite Inorganic materials 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229910052905 tridymite Inorganic materials 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- WDYRPTWUNMHTJL-UHFFFAOYSA-N 2-(carboxymethylsulfonyl)acetic acid Chemical compound OC(=O)CS(=O)(=O)CC(O)=O WDYRPTWUNMHTJL-UHFFFAOYSA-N 0.000 description 1
- JXQCUCDXLSGQNZ-UHFFFAOYSA-N 3-tert-butyl-2-hydroxy-6-methylbenzoic acid Chemical compound CC1=CC=C(C(C)(C)C)C(O)=C1C(O)=O JXQCUCDXLSGQNZ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000005714 Chitosan hydrochloride Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N [H]N1C(=O)CCC1C(=O)O Chemical compound [H]N1C(=O)CCC1C(=O)O ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 description 1
- 229940089960 chloroacetate Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- JDVPQXZIJDEHAN-UHFFFAOYSA-N succinamic acid Chemical compound NC(=O)CCC(O)=O JDVPQXZIJDEHAN-UHFFFAOYSA-N 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- UVZICZIVKIMRNE-UHFFFAOYSA-N thiodiacetic acid Chemical compound OC(=O)CSCC(O)=O UVZICZIVKIMRNE-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
Definitions
- the present invention relates to the field of absorbent articles for personal hygiene, such as sanitary napkins, pantiliners, and incontinence pads. More particularly, the present invention relates to a multicomponent material, which is comprised of chitosan material coated onto an inert carrier material.
- chitosan in absorbent articles for personal hygiene has been disclosed in the literature for various purposes.
- Such exemplary applications of chitosan are, e.g., absorption of saline fluids like urine or absorption of blood or menses.
- Further applications of chitosan have been identified in the field of odor control.
- absorbent articles of personal hygiene such as sanitary napkins, panty liners, diapers, incontinence articles or tampons, comprise an absorbent element for absorbing and retaining fluids.
- absorbent elements are usually constructed of fibers. It has proven most useful to apply the chitosan material in or adjacent to these absorbent elements for maximum functionality.
- Conventionally, such application of chitosan material to fibrous substrates is facilitated by spraying.
- Exemplary processes are disclosed in EP-A-1418953 and EP-A-1425049. Both references teach spraying of a solution of chitosan material with a certain droplet size onto the fibrous substrate. By this, a very defined particle size and a very defined manner of application can be achieved.
- the nature of spraying processes the application will always be superficial, i.e., on the surface of the fibrous substrates.
- the invention is directed to a multicomponent material including an inert carrier material wherein chitosan material is coated onto the inert carrier material.
- the multicomponent material can be incorporated into an absorbent structure.
- the multicomponent material can be incorporated throughout the thickness of an absorbent structure.
- An absorbent article comprising an absorbent structure is also provided.
- inert refers to materials that do not substantially react with water. Further, inert materials herein do not substantially swell, gelify, lose integrity or dissolve when exposed to water.
- Porate material refers to materials, which are present as a multiplicity of discrete particles.
- Such inert carrier material particles can be of any desired shape, e.g., spherical or semi-spherical, cubic, rod-like, polyhedral, etc. Suitable particle shapes herein can be granules, beads, and the like. Shapes having a large greatest dimension/smallest dimension ratio, like needles and flakes, are also contemplated for use herein.
- the inert carrier material particles herein can be used in the form of discrete particles. The size of the inert carrier material particles may vary over a wide range. For reason of industrial hygiene, average particle sizes smaller than about 30 ⁇ m are less desirable.
- Particles having a smallest dimension larger than about 2 mm may also cause a feeling of grittiness in the absorbent article, which is undesirable from a consumer aesthetics standpoint. Furthermore, rate of fluid absorption can be affected by particle size. Larger particles have very much reduced rates of absorption.
- inert carrier material particles substantially all of which have a particle size of from about 50 ⁇ m to about 1500 ⁇ m; from about 100 to about 1000 ⁇ m; or from about 100 to about 600 ⁇ m, can be used. “Particle Size” as used herein means the weighted average of the smallest dimension of the individual particles.
- Suitable inert carrier material particles herein are, for instance, silicon oxide SiO 2 , commonly referred to as sand.
- Suitable SiO 2 material is marketed by Sibelco under the trade name of Silica Sand of Mol M31, M32, M34.
- Other examples are granules of polymeric material, such as polyolefins like polyethylene or polypropylene, or glass beads.
- particles made of porous material like zeolites, can be used. Such porous materials have cavities into which the chitosan material can enter. These materials are inert towards water and other body fluids they may be exposed to in an absorbent article for personal hygiene.
- the inert carrier material is present as fibers. In further embodiments of the present invention the inert carrier material is present as a mixture of fibers and particles.
- the inert carrier material can be provided with a coating of chitosan material on at least part of the surface.
- the chitosan material covers the entire surface of the inert carrier material.
- the chitosan material does not cover more than about 70% of the total surface of the inert carrier material.
- the chitosan material is also present in the interior of the inert carrier material, such as when coating porous inert carrier materials like zeolite particles or when forming agglomerates from individual particles or fibers.
- the chitosan material can have any pH value.
- the chitosan material is acidic.
- the chitosan material can have a pH value of from about 3 to about 6.
- “Acidic” as used herein refers to the property of a material to establish a pH lower than 7 in an aqueous solution.
- Chitosan material it is meant herein chitosans, modified chitosans, crosslinked chitosans, chitosan salts or mixtures thereof.
- Chitosan is a partially or fully deacetylated form of chitin, a naturally occurring polysaccharide. Indeed, chitosan is an aminopolysaccharide usually prepared by deacetylation of chitin (poly-beta(1,4)-N-acetyl-D-glucosamine).
- Chitosan is not a single, definite chemical entity but varies in composition depending on the conditions of manufacture. It may be equally defined as chitin sufficiently deacetylated to form soluble amine salts.
- Chitosan is the beta-(1,4)-polysaccharide of D-glucosamine and is structurally similar to cellulose, except that the C-2 hydroxyl group in cellulose is substituted with a primary amine group in chitosan. The large number of free amine groups makes chitosan a polymeric weak base. Solutions of chitosan are generally highly viscous, resembling those of natural gums.
- the chitosan used herein can be in relatively pure form.
- Methods for the manufacture of pure chitosan are well known. Generally, chitin is milled into a powder and demineralised with an organic acid such as acetic acid. Proteins and lipids are then removed by treatment with a base, such as sodium hydroxide, followed by chitin deacetylation by treatment with concentrated base, such as 40 percent sodium hydroxide. The chitosan formed is washed with water until the desired pH is reached.
- a base such as sodium hydroxide
- chitosan relate to its polyelectrolyte and polymeric carbohydrate character. Thus, it is generally insoluble in water, in alkaline solutions at pH levels above about 7, or in hydrophobic organic solvents. It generally dissolves readily in dilute aqueous solutions of organic acids such as formic, acetic, tartaric, glycolic, lactic and citric acids and also in dilute aqueous solutions of mineral acids, except, for example, sulphuric acid. In general, the amount of acid required to dissolve chitosan is approximately stoichiometric with the amino groups.
- chitosan material can be considered as a linear polyelectrolyte with a high charge density that can interact with negatively charged surfaces such as, for example, proteins (e.g., by interfering with the proteinic wall construction of microorganisms, thereby acting as an antimicrobial agent and/or by reacting with the proteins present in bodily fluid, like menses, thereby acting as a gelifying agent for such fluid).
- negatively charged surfaces such as, for example, proteins
- chitosan material retains electrolyte-containing fluids like body fluids by multiple mechanisms.
- One mechanism is conventional absorption by incorporation of the water dipole molecules into the structure.
- the positively charged quaternary ammonium groups are distracting each other, molecular cavities exist in which water molecules can penetrate. By the penetration of dipole molecules, like water, these cavities can be widened by swelling and thereby generating even more space for further water molecules. This mechanism can be continued until the limits of molecular tension are reached.
- the second mechanism of binding electrolyte-containing fluids like body fluids by chitosan material is gelification.
- Chitosan material acts electrostatically on nearby negatively charged molecules and thereby holds them in its circumference.
- the positively charged cationic groups (e.g., quaternary ammonium groups) of the chitosan material will interact with negatively charged anionic function-bearing molecules present in bodily fluids, like, for example, the carboxylic groups of proteins or cell membrane of red blood cells. This will result in the formation of a three-dimensional network between the chitosan material and such molecules with anionic groups (gelification of the bodily fluids). This gelification will further entrap other molecules present in body fluids (like lipids, acids). Due to the gelification properties of the chitosan material with respect to electrolyte-containing fluids, a liquid barrier is generated when the chitosan material is wetted by such fluids.
- Chitosan materials for use herein can have an average degree of deacetylation (D.A.) of more than about 70%, such as, e.g., from about 80% to about 100%.
- the degree of deacetylation refers to the percentage of the amine groups that are deacetylated. This characteristic is directly related to the hydrogen bonding existing in this biopolymer, affecting its structure, solubility and ultimately its reactivity.
- the degree of deacetylation can be determined by, e.g., titration, dye adsorption, UV/vis, IR and NMR spectroscopy.
- the degree of deacetylation will influence the cationic properties of chitosan. By increasing the degree of deacetylation, the cationic character of the chitosan material can increase and thus also its gelifying abilities.
- Suitable chitosan materials for use herein include substantially water-soluble chitosan.
- a material will be considered water-soluble when it substantially dissolves in excess water to form a clear and stable solution, thereby losing its initially particulate form and becoming essentially molecularly dispersed throughout the water solution.
- Chitosan materials for use herein are water soluble, i.e., at least about 1 gram and at least about 3 grams of the chitosan materials are soluble in 100 grams of water at 25° C. and one atmosphere.
- solubility of a given compound, it is to be understood herein as the amount of said compound solubilised in deionised water at 25° C. and one atmosphere in absence of a precipitate.
- the water-soluble chitosan materials will be free from a higher degree of crosslinking, as crosslinking tends to render the chitosan materials water insoluble.
- Chitosan materials may generally have a wide range of molecular weights. Chitosan materials with a wide range of molecular weights are suitable for use in the present invention. Typically, chitosan materials for use herein have a molecular weight ranging from about 1,000 to about 10,000,000 grams per gram moles or from about 2,000 to about 1,000,000 grams per gram moles. Molecular weight means average molecular weight. Methods for determining the average molecular weight of chitosan materials are known to those skilled in the art. Typical methods include, for example, light scattering, intrinsic viscosity and gel permeation chromatography.
- a chitosan material it is generally most convenient to express the molecular weight of a chitosan material in terms of its viscosity in a 1.0 weight percent aqueous solution at 25° C. with a Brookfield viscometer. It is common to indirectly measure the viscosity of the chitosan material by measuring the viscosity of a corresponding chitosan salt, such as by using a 1.0 weight percent acetic acid aqueous solution. Chitosan materials suitable for use in the present invention will suitably have a viscosity in a 1.0 weight-% aqueous solution at 25° C.
- the pH of the chitosan materials depends on their preparation. Chitosan materials for use herein have an acidic pH, typically in the range of about 3 to about 7, such as, e.g., about 5.
- pH of the chitosan material it is meant herein the pH of a 1% chitosan material solution (1 gram of chitosan material dissolved in 100 grams of distilled water) measured by a pH-meter.
- a more acidic pH the cationic character of the chitosan materials will be increased and thus their gelifying abilities.
- too high acidity is detrimental to skin safety.
- chitosan materials with a pH of about 5 are used, thereby delivering the best compromise between fluid handling properties on one side and skin compatibility on the other side.
- Suitable chitosan materials for use herein include chitosan salts, such as, e.g., water-soluble chitosan salts.
- chitosan salts such as, e.g., water-soluble chitosan salts.
- a variety of acids can be used for forming chitosan salts.
- suitable acids for use are soluble in water or partially soluble in water, are sufficiently acidic to form the ammonium salt of chitosan and yet not sufficiently acidic to cause hydrolysis of chitosan, and are present in an amount sufficient to protonate the reactive sites of chitosan.
- Suitable acids can be represented by the formula: R—(COOH) n wherein n has a value of 1 to 3 and R represents a mono- or divalent organic radical composed of carbon, hydrogen and optionally at least one of oxygen, nitrogen and sulphur or simply R is a hydrogen atom.
- the acids are the mono- and dicarboxylic acids composed of carbon, hydrogen, oxygen and nitrogen (also called hereinafter amino acids). Such acids are biologically acceptable for use against or in proximity to the human body.
- Illustrative acids include, among others, citric acid, formic acid, acetic acid, N-acetylglycine, acetylsalicylic acid, fumaric acid, glycolic acid, iminodiacetic acid, itaconic acid, lactic acid, maleic acid, malic acid, nicotinic acid, 2-pyrrolidone-5-carboylic acid, salycilic acid, succinamic acid, succinic acid, ascorbic acid, aspartic acid, glutamic acid, glutaric acid, malonic acid, pyruvic acid, sulfonyldiacetic acid, benzoic acid, epoxysuccinic acid, adipic acid, thiodiacetic acid and thioglycolic acid. Any chitosan salts formed from the reaction of chitosan with any of these acids or any other suitable acid are suitable for use herein.
- chitosan salts formed with an inorganic acid include, but are not limited to, chitosan hydrochloride, chitosan hydrobromide, chitosan phosphate, chitosan sulphonate, chitosan chlorosulphonate, chitosan chloroacetate and mixtures thereof.
- chitosan salts formed with an organic acid include, but are not limited to, chitosan formate, chitosan acetate, chitosan lactate, chitosan glycolate, chitosan malonate, chitosan epoxysuccinate, chitosan benzoate, chitosan adipate, chitosan citrate, chitosan salicylate, chitosan propionate, chitosan nitrilotriacetate, chitosan itaconate, chitosan hydroxyacetate, chitosan butyrate, chitosan isobutyrate, chitosan acrylate and mixtures thereof. It is also suitable to form a chitosan salt using a mixture of acids including, for example, both inorganic and organic acids.
- chitosan salts for use herein are those formed by the reaction of chitosan with an amino acid.
- Amino acids are molecules containing both an acidic and amino functional group. The use of amino acids is desirable as those chitosan amino salts have higher skin compatibility. Indeed, most of the amino acids are naturally present on the skin.
- Chitosan salts of pyrrolidone carboxylic acid are effective moisturizing agents and are non-irritating to skin.
- Amino acids for use herein include both linear and/or cyclo amino acids.
- amino acids for use herein include, but are not limited to, alanine, valine, leucine, isoleucine, proline, phenylalanine, tryptophan, methionine, glycine, serine, cysteine, tyrosine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine, histidine, hydroxyproline, threonine, and the like.
- An example of a cyclic amino acid is pyrrolidone carboxylic acid, which is a carboxylic acid of pyrrolidin-2-one as per following formula:
- chitosan materials suitable for use herein include cross-linked chitosans with a low degree of cross-linkage and modified chitosans.
- Suitable crosslinking agents for use herein are organic compounds having at least two functional groups or functionalities capable of reacting with active groups located on the chitosan materials. Examples of such active groups include, but are not limited to, carboxylic acid(—COOH), amino (—NH 2 ), or hydroxyl (—OH) groups.
- suitable crosslinking agents include, but are not limited to, diamines, polyamines, diols, polyols, dicarboxylic acids, polycarboxylic acids, aminocarboxylic acids, aminopolycarboxylic acids, polyoxides and the like.
- One way to introduce a crosslinking agent with the chitosan material solution is to mix the crosslinking agent with chitosan during preparation of the solution.
- Another suitable crosslinking agent comprises a metal ion with more than two positive charges, such as Ca 2+ , Al 3+ , Fe 3+ , Ce 3+ , Ce 4+ , Ti 4+ , Zr 4+ and Cr 3+ . Since the cations on chitosan possess antimicrobial properties, in one embodiment a crosslinking agent reacting to the cations is not used, unless no alternative crosslinking agent is available.
- chitosan material is commercially available from numerous vendors. Exemplary commercially available chitosan materials are those available from for example the Vanson Company.
- the chitosan salt for use herein is chitosan pyrrolidone carboxylate (also called chitosonium pyrrolidone carboxylate), which has a degree of deacetylation of more than about 85%, a water solubility of about 1% (1 gram is soluble in 100 grams of distilled water at 25° C. and one atmosphere) and a pH of about 5.
- Chitosonium pyrrolidone carboxylate is commercially available under the name Kytamer® PC from Amerchol Corporation.
- Another exemplary chitosan salt for use herein is chitosan lactate, the chitosan salt of lactic acid.
- the chitosan material is coated onto the inert carrier material at a thickness of from about 1 to about 100 ⁇ m or from about 5 to about 30. Further, in one embodiment, the weight ratio of the inert carrier material to the chitosan material is from about 99:1 to about 1:99, or from about 95:5 to about 30:70.
- the coating of the inert carrier material with chitosan material may be facilitated by any known coating method, for example, by mixing or dispersing the inert carrier material in a solution or dispersion of the chitosan material; by spraying the chitosan material solution or dispersion onto the inert carrier material; by introducing the chitosan material dispersion or solution and the inert carrier material in a fluidised bed or Wurster coater; by agglomerating the chitosan material solution or dispersion and the inert carrier material; by dip-coating the inert carrier material in the chitosan material dispersion or solution.
- Useful fluidized bed reactors include, for example, the fluidized or suspended bed coaters familiar in the pharmaceutical industry.
- the coating is facilitated by the Wurster process known to those skilled in the art.
- suitable mixers include for example twin drum mixers, so called “Zig-Zag” mixers, plough-share mixers, such as Lödige mixers, cone screw mixers, or perpendicularly cylindrical mixers having coaxially rotating blades. Examples of coating processes are, for example, described in U.S. Pat. Nos. 5,840,329 and 6,387,495.
- absorbent structure is used herein to describe absorbent webs suitable for use in absorbent articles.
- the absorbent structure comprises two surfaces aligned substantially opposite to each other. The first and the second surface are spaced apart from each other by the thickness dimension of the absorbent structure.
- the absorbent structure comprises the multicomponent material of the present invention.
- the absorbent structure according to the present invention can be used as absorbent core or so-called secondary topsheet or secondary backsheet in absorbent articles.
- the absorbent structure typically has significant internal void space in the form of pores, holes, apertures, interstitial space between fibers and the like.
- absorbent structures for use in the present invention are fibrous webs, such as nonwovens or fabrics, comprising natural or synthetic fibers or mixtures thereof, or apertured polymeric films or foam materials.
- the absorbent structure according to the present invention can be made of any of a variety of fibers, including a blend or admixture.
- the fibers may be cellulosic, modified cellulosic, or hydrophilic synthetic and include such fibers as wood pulp, rayon, cotton, cellulose acetate, polyester, nylon and the like.
- the absorbent structure can be made according to any suitable method known for this purpose in the art. Fibrous absorbent structures according to the present invention can be made by appropriate processes such as dry laying and in particular air laying, melt blowing or spunbonding. Film-like or foam-like absorbent structures according to the present invention are made by processes suitable for such purposes.
- absorbent structures for use herein are hydrophilic fibrous webs.
- hydrophilic refers to a material having a contact angle of water in air of less than about 90 degrees
- hydrophobic refers to a material having a contact angle of water in air of about 90 degrees or greater.
- An absorbent structure comprising hydrophilic fibers, like, for example, cellulosic fibers, such as wood pulp fibers, is useful in such products as sanitary napkins, disposable diapers or wipes, because the hydrophilic fibers are liquid absorbent and therefore enhance the overall absorbency of the absorbent structure.
- Absorbent structures for use herein can be made of a blend of cellulosic and hydrophilic synthetic fibers, for example, comprising about 65% to about 95% by weight of cellulosic fibers and up to about 20% by weight of the hydrophilic synthetic fibers.
- the hydrophilic synthetic fibers which can be provided in any length including staple length, can improve the strength of the absorbent structure.
- Hydrophobic fibers or films, such as fibers or films made of polyethylene or polypropylene, may also be used in the absorbent structure herein provided they are treated by, e.g., surfactants to make them hydrophilic, in order not to decrease the absorbent capacity of the absorbent structure.
- the absorbent structure is mainly made of foam material, into which the multicomponent material is distributed.
- the absorbent structure of the present invention can be comprised of one layer only. Alternatively, the absorbent structure herein can also be comprised of multiple layers. In one embodiment, the absorbent structure herein also comprises superabsorbent material for absorbing aqueous body fluids. Such superabsorbent materials are well-known in the art, such as, e.g., polyacrylates or hydroxymethylcellulose.
- the absorbent structure according to the present invention can be described as having an extension in all of the x, y and z-dimensions in an orthogonal Cartesian system.
- the multicomponent material is in one embodiment relatively evenly distributed throughout the absorbent structure, thus throughout its whole extension across in said x, y and z-dimension.
- the multicomponent material of the present invention is not evenly distributed in the absorbent structure but concentrated in certain regions of it.
- the multicomponent material is present on the bottom of the absorbent structure for immobilizing liquid at the bottom of the absorbent structure.
- the multicomponent material is arranged at the periphery of the absorbent structure, which prevents liquid from running of the absorbent at the sides.
- the absorbent structure according to the present invention is used in the absorbent core of an absorbent article.
- the term “absorbent article” is used herein in a very broad sense including any article able to receive and/or absorb and/or contain and/or retain fluids and/or exudates, especially bodily fluids/bodily exudates.
- the absorbent article comprises a fluid pervious topsheet, a fluid impervious backsheet that can be water vapour and/or gas pervious, and an absorbent core comprised there between.
- the absorbent articles can be disposable absorbent articles.
- Typical disposable absorbent articles according to the present invention are diapers, surgical and wound dressings and perspiration pads, incontinence pads, and absorbent articles for feminine hygiene like sanitary napkins, panty liners, tampons, interlabial devices or the like.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05013435 | 2005-06-22 | ||
EP05013435A EP1736178B1 (de) | 2005-06-22 | 2005-06-22 | Mehrkomponentenmaterial mit Chitosan Material und dieses enthaltende absorbierende Gegenstände |
EP05013435.2 | 2005-06-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
US20070009581A1 US20070009581A1 (en) | 2007-01-11 |
US8231893B2 true US8231893B2 (en) | 2012-07-31 |
Family
ID=35344667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/471,929 Active 2029-08-13 US8231893B2 (en) | 2005-06-22 | 2006-06-21 | Multicomponent material comprising chitosan |
Country Status (5)
Country | Link |
---|---|
US (1) | US8231893B2 (de) |
EP (1) | EP1736178B1 (de) |
AT (1) | ATE426418T1 (de) |
DE (1) | DE602005013502D1 (de) |
WO (1) | WO2007002046A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9539279B2 (en) | 2013-08-08 | 2017-01-10 | Hans Werner Bottesch | System for improving safety and efficacy in the preparation of an injection site |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006008534A1 (de) | 2006-02-22 | 2007-08-30 | Stiftung Nano Innovations - For A Better Living, Olten | Behälterverschlussbeschichtungszusammensetzung, Behälterverschlussbeschichtung, deren Herstellung und Anwendung |
DE102006008535A1 (de) | 2006-02-22 | 2007-08-30 | Stiftung Nano Innovations - For A Better Living, Olten | Anitbakterielle Beschichtungszusammensetzung auf Basis eines Siliziumdioxid erzeugenden Mittels, ein Anwendungsset, eine nanoskalige Beschichtung, die Herstellung der Beschichtung, die Weiterverarbeitung der Beschichtung sowie deren Verwendung |
GB2461019B (en) | 2008-04-25 | 2013-06-05 | Medtrade Products Ltd | Haemostatic material |
ES2422282T3 (es) * | 2008-05-19 | 2013-09-10 | Procter & Gamble | Núcleo absorbente |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0393825B1 (de) | 1989-04-21 | 1994-06-15 | Japan as represented by Director-General, Agency of Industrial Science and Technology | Wasser absorbierendes Verbundmaterial und Verfahren zu seiner Herstellung |
EP0437816B1 (de) | 1990-01-16 | 1995-07-26 | Hoechst Celanese Corporation | Superabsorbierende, nassgelegte, nichtgewebte Faserbahn |
US6197322B1 (en) * | 1997-12-23 | 2001-03-06 | Kimberly-Clark Worldwide, Inc. | Antimicrobial structures |
WO2003018074A2 (en) | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Absorbent member with improved fluid handling agent |
WO2003018073A2 (en) | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Absorbent article with film-like region of chitosan material |
US20040166307A1 (en) | 2001-08-24 | 2004-08-26 | The Procter & Gamble Company | Absorbent member with improved fluid handling agent |
US20040167487A1 (en) | 2001-08-24 | 2004-08-26 | The Procter & Gamble Company | Absorbent article with film-like region of chitosan material and process for making the same |
US20050003725A1 (en) | 2001-06-29 | 2005-01-06 | The Procter & Gamble Company | Absorbent article |
US20050154364A1 (en) | 2003-12-23 | 2005-07-14 | The Procter & Gamble Company | Superabsorbent material and absorbent articles containing said material |
US20060171999A1 (en) * | 2005-01-31 | 2006-08-03 | John Haozhong Xin | Textiles with chitosan core-shell particles |
US7291674B2 (en) * | 2003-10-28 | 2007-11-06 | Stockhausen, Inc. | Superabsorbent polymer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840329A (en) | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
US6387495B1 (en) | 1999-04-16 | 2002-05-14 | Kimberly-Clark Worldwide, Inc. | Superabsorbent-containing composites |
-
2005
- 2005-06-22 DE DE602005013502T patent/DE602005013502D1/de active Active
- 2005-06-22 AT AT05013435T patent/ATE426418T1/de not_active IP Right Cessation
- 2005-06-22 EP EP05013435A patent/EP1736178B1/de active Active
-
2006
- 2006-06-20 WO PCT/US2006/023921 patent/WO2007002046A1/en active Application Filing
- 2006-06-21 US US11/471,929 patent/US8231893B2/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0393825B1 (de) | 1989-04-21 | 1994-06-15 | Japan as represented by Director-General, Agency of Industrial Science and Technology | Wasser absorbierendes Verbundmaterial und Verfahren zu seiner Herstellung |
EP0437816B1 (de) | 1990-01-16 | 1995-07-26 | Hoechst Celanese Corporation | Superabsorbierende, nassgelegte, nichtgewebte Faserbahn |
US6197322B1 (en) * | 1997-12-23 | 2001-03-06 | Kimberly-Clark Worldwide, Inc. | Antimicrobial structures |
US20050003725A1 (en) | 2001-06-29 | 2005-01-06 | The Procter & Gamble Company | Absorbent article |
WO2003018074A2 (en) | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Absorbent member with improved fluid handling agent |
WO2003018073A2 (en) | 2001-08-24 | 2003-03-06 | The Procter & Gamble Company | Absorbent article with film-like region of chitosan material |
US20040166307A1 (en) | 2001-08-24 | 2004-08-26 | The Procter & Gamble Company | Absorbent member with improved fluid handling agent |
US20040167487A1 (en) | 2001-08-24 | 2004-08-26 | The Procter & Gamble Company | Absorbent article with film-like region of chitosan material and process for making the same |
US7291674B2 (en) * | 2003-10-28 | 2007-11-06 | Stockhausen, Inc. | Superabsorbent polymer |
US20050154364A1 (en) | 2003-12-23 | 2005-07-14 | The Procter & Gamble Company | Superabsorbent material and absorbent articles containing said material |
US20060171999A1 (en) * | 2005-01-31 | 2006-08-03 | John Haozhong Xin | Textiles with chitosan core-shell particles |
Non-Patent Citations (1)
Title |
---|
European Search Report dated Dec. 1, 2005. |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9539279B2 (en) | 2013-08-08 | 2017-01-10 | Hans Werner Bottesch | System for improving safety and efficacy in the preparation of an injection site |
Also Published As
Publication number | Publication date |
---|---|
EP1736178A1 (de) | 2006-12-27 |
ATE426418T1 (de) | 2009-04-15 |
DE602005013502D1 (de) | 2009-05-07 |
US20070009581A1 (en) | 2007-01-11 |
EP1736178B1 (de) | 2009-03-25 |
WO2007002046A1 (en) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7537832B2 (en) | Superabsorbent material and absorbent articles containing said material | |
EP1931398B1 (de) | Saugfähiger artikel mit einem einen wirkstoff enthaltenden dünnfilm | |
KR0131462B1 (ko) | 실금증 환자를 위한 일회용 흡수 제품 | |
US6867287B2 (en) | Breathable absorbent articles comprising chitosan material | |
US8231893B2 (en) | Multicomponent material comprising chitosan | |
KR20020093080A (ko) | 음이온성 흡수성 겔화 물질을 포함하는 키토산 물질 | |
RU2385738C2 (ru) | Впитывающее изделие, содержащее тонкую пленку, включающую активное вещество | |
KR100632869B1 (ko) | 키토산 물질을 포함하는 통기성 흡수 제품 | |
US20040167487A1 (en) | Absorbent article with film-like region of chitosan material and process for making the same | |
US20040166307A1 (en) | Absorbent member with improved fluid handling agent | |
MXPA02010031A (es) | Articulos absorbentes que comprenden un polisacarido cationico y silice. | |
EP1287836B1 (de) | Absorbierendes Element mit verbessertem Flüssigkeitshandhabbarkeitsmittel | |
EP1287837B1 (de) | Atmungsaktive absorbierende Artikel mit filmähnlichem Chitosanmaterial und Verfahren zu deren Herstellung | |
EP1287835A1 (de) | Mit Chitosan beschichtetes Vlies und Verfahren zu dessen Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PROCTER & GAMBLE COMPANY, THE, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CARLUCCI, GIOVANNI;MEO, DANIELA;TAMBURRO, MAURIZIO;AND OTHERS;SIGNING DATES FROM 20060821 TO 20060908;REEL/FRAME:018297/0431 Owner name: PROCTER & GAMBLE COMPANY, THE, OHIO Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CARLUCCI, GIOVANNI;MEO, DANIELA;TAMBURRO, MAURIZIO;AND OTHERS;REEL/FRAME:018297/0431;SIGNING DATES FROM 20060821 TO 20060908 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |